SDC1 and prostate carcinoma: Associations of the high CD138 expression with unfavorable tumor phenotype, such as early recurrence, high Gleason grade, and poor patient outcome, had already been suggested by other studies investigating 18-551 prostate cancers by IHC [11, 15, 16, 19–22, 24–26].